Good morning :)
Switch to
Place Order

SMS Pharmaceuticals Ltd

SMSPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹736 cr, stock is ranked 1,131
Moderate RiskStock is 2.35x as volatile as Nifty
87.050.40% (+0.35)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹736 cr, stock is ranked 1,131
Moderate RiskStock is 2.35x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
10.861.790.34%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
38.164.820.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

SMS Pharmaceuticals Limited is engaged in manufacturing and sale of bulk drugs and active pharmaceutical ingredients (APIs), and their intermediates.

Investor PresentationView older 

Jun 2, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+468.31+417.06+566.62+525.07+40.04+31.57+62.51+67.87
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 3.12%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Schedule of Analysts/Institutional Investor Meet/Con. Call 
Announced OnAug 11, 2022

SMS Pharmaceuticals Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

SMS Pharmaceuticals Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

Cessation 
Announced OnAug 8, 2022

SMS Pharmaceuticals Limited has informed the Exchange about cessation of Shilpa R Waghmare as Nominee Director of the company w.e.f. 08-Aug-2022 | Download

SMS Pharmaceuticals Limited has informed the Exchange about cessation of Shilpa R Waghmare as Nominee Director of the company w.e.f. 08-Aug-2022 | Download

Cash Dividend 
Ex. DateSep 22, 2021

Final • Div/Share: ₹ 0.3

See all events